SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001140361-17-000406
Filing Date
2017-01-04
Accepted
2017-01-04 16:33:16
Documents
1
Group Members
JAMES W. TRAWEEK, JR.R. KENT MCGAUGHY, JR.

Document Format Files

Seq Description Document Type Size
1 CPMG, INC. SC 13DA 12-30-2016 (REATA PHARMACEUTICALS, INC.) formsc13da.htm SC 13D/A 224908
  Complete submission text file 0001140361-17-000406.txt   226443
Mailing Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063
Business Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063 972-865-2206
REATA PHARMACEUTICALS INC (Subject) CIK: 0001358762 (see all company filings)

IRS No.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-89517 | Film No.: 17506030
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2000 MCKINNEY SUITE 2125 DALLAS TX 75201
Business Address 2000 MCKINNEY SUITE 2125 DALLAS TX 75201 214-871-6816
CPMG Inc (Filed by) CIK: 0001372218 (see all company filings)

IRS No.: 770616887 | State of Incorp.: TX | Fiscal Year End: 1231
Type: SC 13D/A